| P2093 | author name string | Michael Kahn | |
| | Yong-Mi Kim | |
| | Eun-Ji Gang | |
| P2860 | cites work | Bcr interferes with beta-catenin-Tcf1 interaction | Q24302316 |
| | Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis | Q24307566 |
| | Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation | Q24535750 |
| | PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees | Q24595315 |
| | Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling | Q24658040 |
| | To wake up cancer stem cells, or to let them sleep, that is the question | Q26749632 |
| | Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia? | Q26766395 |
| | Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options | Q27028181 |
| | Stem cells, cancer, and cancer stem cells | Q27860878 |
| | Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 |
| | Quantification of crypt and stem cell evolution in the normal and neoplastic human colon | Q28246034 |
| | Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor | Q28286827 |
| | Balancing cell adhesion and Wnt signaling, the key role of beta-catenin | Q28288763 |
| | Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5 | Q28591430 |
| | A role for Wnt signalling in self-renewal of haematopoietic stem cells | Q28592213 |
| | Wnt signaling promotes reprogramming of somatic cells to pluripotency | Q28741624 |
| | The difficulty of targeting cancer stem cell niches | Q28744461 |
| | Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation | Q41869389 |
| | Genetic activation of Hedgehog signaling unbalances the rate of neural stem cell renewal by increasing symmetric divisions. | Q42108815 |
| | Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. | Q42140104 |
| | The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. | Q42723875 |
| | β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis | Q42860097 |
| | Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells | Q42938783 |
| | A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance | Q43195305 |
| | CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis | Q43211619 |
| | Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice | Q43871563 |
| | sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia | Q46177631 |
| | beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia | Q46345796 |
| | Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. | Q47247972 |
| | Chronic versus acute myelogenous leukemia: a question of self-renewal. | Q52062147 |
| | Orchestrating Wnt signalling for metabolic liver zonation. | Q52873023 |
| | The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. | Q53370119 |
| | Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. | Q54351186 |
| | Gone but not forgotten | Q57277008 |
| | E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators | Q64383507 |
| | Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia | Q80575693 |
| | Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis | Q81250982 |
| | Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin | Q81375017 |
| | Anaerobicizing into pluripotency | Q84625092 |
| | Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency | Q85207580 |
| | Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. | Q39219232 |
| | The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells | Q39620090 |
| | β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells | Q39620290 |
| | Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines | Q40183840 |
| | Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors | Q40252079 |
| | SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling | Q40314265 |
| | Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression | Q40443907 |
| | Beta-catenin signaling is required for neural differentiation of embryonic stem cells | Q40533744 |
| | Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy | Q40607863 |
| | mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. | Q41290971 |
| | Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML | Q29614278 |
| | Mutation selection and the natural history of cancer | Q29614279 |
| | Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor | Q29614622 |
| | WNT signalling pathways as therapeutic targets in cancer | Q29615666 |
| | mTOR signaling at a glance | Q29619857 |
| | A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] | Q31106002 |
| | Genetic regulation of primitive hematopoietic stem cell senescence | Q33180235 |
| | Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation | Q33732463 |
| | CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells | Q33926141 |
| | Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts | Q33978433 |
| | Analysis of the coding genome of diffuse large B-cell lymphoma | Q34205133 |
| | CREBBP mutations in relapsed acute lymphoblastic leukaemia | Q34792792 |
| | Wnt/catenin signaling in adult stem cell physiology and disease | Q34959673 |
| | β-Catenin is required for Ron receptor-induced mammary tumorigenesis | Q35100064 |
| | O2 regulates stem cells through Wnt/β-catenin signalling. | Q35129302 |
| | Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia | Q35182716 |
| | Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP | Q35185929 |
| | Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group | Q35220417 |
| | Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin | Q35505126 |
| | Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency | Q35720762 |
| | Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells | Q35763204 |
| | Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model | Q35858574 |
| | Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling | Q35993601 |
| | Targeting survivin and p53 in pediatric acute lymphoblastic leukemia. | Q35999249 |
| | Wnt/beta-catenin pathway | Q36043253 |
| | Investigating Wnt signaling: a chemogenomic safari | Q36294110 |
| | Lineage-specific requirements of beta-catenin in neural crest development | Q36324290 |
| | Stem cells in the etiology and treatment of cancer | Q36353139 |
| | Nuclear Receptors in Regulation of Mouse ES Cell Pluripotency and Differentiation | Q36445376 |
| | Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells | Q36463590 |
| | Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia | Q36474886 |
| | Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo | Q36488720 |
| | Wnt/beta-catenin signaling in cancer stemness and malignant behavior | Q36738603 |
| | Beyond β-catenin: prospects for a larger catenin network in the nucleus | Q36837381 |
| | Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells | Q36850854 |
| | Stem cell metabolism in tissue development and aging | Q36883218 |
| | The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases | Q36951804 |
| | Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours | Q37025924 |
| | Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion | Q37056272 |
| | Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation | Q37059643 |
| | Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang | Q37094051 |
| | Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia | Q37112076 |
| | Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness | Q37174369 |
| | Endogenous knockdown of survivin improves chemotherapeutic response in ALL models | Q37324196 |
| | Evolution of energy metabolism, stem cells and cancer stem cells: how the warburg and barker hypotheses might be linked. | Q37344013 |
| | Self-renewal capacity is a widespread property of various types of neural crest precursor cells | Q37357957 |
| | The hematopoietic stem-cell niche in health and leukemia | Q37610816 |
| | The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia. | Q37640904 |
| | Preleukemia: one name, many meanings | Q37683379 |
| | Functional heterogeneity of genetically defined subclones in acute myeloid leukemia | Q37698123 |
| | Targeting Notch to target cancer stem cells. | Q37763414 |
| | Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 |
| | Molecular pathways to CML stem cells | Q37763635 |
| | The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators | Q37797633 |
| | Maintenance of genomic integrity in hematopoietic stem cells | Q37850700 |
| | Drugging Wnt signalling in cancer | Q38012254 |
| | On the role of Wnt/β-catenin signaling in stem cells | Q38044161 |
| | The complex world of WNT receptor signalling | Q38059785 |
| | Targeting chronic myeloid leukemia stem cells. | Q38069545 |
| | An evolutionary perspective on chronic myelomonocytic leukemia. | Q38096235 |
| | Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. | Q38143364 |
| | Surviving change: the metabolic journey of hematopoietic stem cells. | Q38207310 |
| | Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia. | Q38588880 |
| | The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development | Q38632898 |
| | The bone marrow microenvironment - Home of the leukemic blasts | Q38742913 |
| | The chronic myeloid leukemia stem cell: stemming the tide of persistence | Q38761787 |
| | Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. | Q38786359 |
| | Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia | Q38867041 |
| | Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcription | Q39005602 |
| | Myeloid malignancies and the microenvironment | Q39073878 |
| P304 | page(s) | 1-11 | |
| P577 | publication date | 2017-05-04 | |
| P1433 | published in | Experimental Hematology | Q5421109 |
| P1476 | title | CBP/Catenin antagonists: Targeting LSCs' Achilles heel | |
| P478 | volume | 52 | |